CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,741,000 | -20.9% | 745,486 | +29.7% | 0.81% | +18.1% |
| Q4 2019 | $5,990,000 | -50.4% | 574,616 | -81.3% | 0.69% | -33.7% |
| Q3 2019 | $12,079,000 | -20.9% | 3,073,550 | +199.3% | 1.04% | -8.9% |
| Q2 2019 | $15,271,000 | +22.6% | 1,026,975 | +104.7% | 1.14% | +27.1% |
| Q1 2019 | $12,453,000 | +82.4% | 501,724 | +32.0% | 0.90% | +58.4% |
| Q4 2018 | $6,828,000 | – | 380,173 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |